NCT03517449lenvatinibpembrolizumabdoxorubicinpaclitaxel
…Background In Study 309/KEYNOTE-775 ( NCT03517449), lenvatinib+pembrolizumab versus chemotherapy significantly im…
1articles mentioning funders
1funder mentions
1distinct funders extracted
0%of mentions human-reviewed
Active filtersEntity: NCT03517449 ×
NCT03517449
This funder is selected. Its supporting articles are shown below.